AAAAAA
Results: 1-25/139
Authors:
NONY P
CUCHERAT M
BOISSEL JP
Citation: P. Nony et al., REVISITING THE EFFECT COMPARTMENT THROUGH TIMING ERRORS IN DRUG ADMINISTRATION, Trends in pharmacological sciences, 19(2), 1998, pp. 49-54
Authors:
IBE W
BUERKE M
GROSSER T
BOISSEL JP
MEYER J
DARIUS H
Citation: W. Ibe et al., NO DONORS INDUCE APOPTOSIS IN VASCULAR SMOOTH-MUSCLE CELLS IN-VITRO, Journal of vascular research, 35(3), 1998, pp. 5-5
Authors:
BOISSEL JP
CUCHERAT M
Citation: Jp. Boissel et M. Cucherat, THE METAANALYSIS OF DIAGNOSTIC-TEST STUDIES, European radiology, 8(3), 1998, pp. 484-487
Authors:
BOISSEL JP
CUCHERAT M
GUEYFFIER F
Citation: Jp. Boissel et al., WHAT TARGET FOR GUIDELINES - UNIFORMED OR TAILORED, American journal of hypertension, 11(7), 1998, pp. 890-893
Authors:
FORSTERMANN U
BOISSEL JP
KLEINERT H
Citation: U. Forstermann et al., EXPRESSIONAL CONTROL OF THE CONSTITUTIVE ISOFORMS OF NITRIC-OXIDE SYNTHASE (NOS-I AND NOS-III), The FASEB journal, 12(10), 1998, pp. 773-790
Authors:
CUCHERAT M
BOISSEL JP
Citation: M. Cucherat et Jp. Boissel, A MATHEMATICAL-MODEL FOR THE DETERMINATION OF THE OPTIMUM VALUE OF THE TREATMENT THRESHOLD FOR A CONTINUOUS RISK FACTOR, European journal of epidemiology, 14(1), 1998, pp. 23-29
Authors:
GIRARD P
NONY P
ERHARDTSEN E
DELAIR S
FFRENCH P
DECHAVANNE M
BOISSEL JP
Citation: P. Girard et al., POPULATION PHARMACOKINETICS OF RECOMBINANT FACTOR VIIA IN VOLUNTEERS ANTICOAGULATED WITH ACENOCOUMAROL, Thrombosis and haemostasis, 80(1), 1998, pp. 109-113
Authors:
LI W
GUEYFFIER F
BOISSEL JP
GIRARD P
BOUTITIE F
CUCHERAT M
Citation: W. Li et al., IDENTIFICATION AND PREDICTION OF RESPONDERS TO A THERAPY - A MODEL AND ITS PRELIMINARY APPLICATION TO HYPERTENSION, Journal of hypertension, 16(7), 1998, pp. 1064-1064
Authors:
TRILLETLENOIR V
CUCHERAT M
GERARD JP
BOISSEL JP
Citation: V. Trilletlenoir et al., MAINTENANCE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER, Lung cancer, 21(3), 1998, pp. 221-223
Authors:
GUEYFFIER F
BOISSEL JP
Citation: F. Gueyffier et Jp. Boissel, HYPERTENSION OPTIMAL TREATMENT (HOT) TRIAL, Lancet, 352(9127), 1998, pp. 572-573
Authors:
DUBOIS V
RACHET F
AULAGNER G
BOISSEL JP
Citation: V. Dubois et al., PHOLY - DRUG UTILIZATION IN CIVIL HOSPICE S OF LYON - A PHARMACOEPIDEMIOLOGIC INVESTIGATION - METHODOLOGY AND DIFFICULTIES, Therapie, 53(2), 1998, pp. 151-155
Authors:
RACHET F
BOISSEL JP
DUBOIS V
AULAGNER G
Citation: F. Rachet et al., PHOLY - PILOT-STUDY OF DRUG UTILIZATION I N CIVIL HOSPICES OF LYON - RESULTS, Therapie, 53(2), 1998, pp. 157-164
CONSEQUENCES OF TIMING ERRORS IN DRUG INTAKE ON THE PHARMACOLOGICAL RESPONSE - A SIMULATION APPROACH
Authors:
NONY P
CUCHERAT M
BOISSEL JP
Citation: P. Nony et al., CONSEQUENCES OF TIMING ERRORS IN DRUG INTAKE ON THE PHARMACOLOGICAL RESPONSE - A SIMULATION APPROACH, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 486-486
Authors:
NONY P
GIRARD P
DELAIR S
FAYN J
FORLINI MC
ARNAUD P
RUBEL P
VIOLET I
LEREBOURS G
BOISSEL JP
Citation: P. Nony et al., ELECTROPHYSIOLOGIC EFFECTS OF S16257-2, A SINOATRIAL MODULATOR AGENT,IN HEALTHY-SUBJECTS - A SURFACE ECG STUDY, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 3644-3644
Authors:
NONY P
DELAIR S
GIRARD P
FAYN J
FORLINI MC
ARNAUD P
RUBEL P
RESPLANDY G
LEREBOURS G
BOISSEL JP
Citation: P. Nony et al., DOSE-EFFECT RELATIONSHIP AFTER ADMINISTRATION OF 10, 20 AND 30 MG OF S16257-2, A SINOATRIAL MODULATOR AGENT, IN HEALTHY-SUBJECTS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4616-4616
Authors:
VEIT K
BOISSEL JP
GROSSER T
BINZ C
GRONING AK
DARIUS H
Citation: K. Veit et al., GENE-TRANSFER OF HUMAN NITRIC-OXIDE SYNTHASE TYPE-II INTO RABBIT VASCULAR SMOOTH-MUSCLE CELLS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 37-37
Authors:
SCHWARZ PM
GIERTEN B
BOISSEL JP
FORSTERMANN U
Citation: Pm. Schwarz et al., EXPRESSIONAL DOWN-REGULATION OF NEURONAL-TYPE NITRIC-OXIDE SYNTHASE-IBY GLUCOCORTICOIDS IN N1E-115 NEUROBLASTOMA-CELLS, Molecular pharmacology, 54(2), 1998, pp. 258-263
THE CALCULATION OF A CONFIDENCE-INTERVAL ON THE ABSOLUTE ESTIMATED BENEFIT FOR AN INDIVIDUAL PATIENT
Authors:
LI W
GIRARD P
BOISSEL JP
GUEYFFIER F
Citation: W. Li et al., THE CALCULATION OF A CONFIDENCE-INTERVAL ON THE ABSOLUTE ESTIMATED BENEFIT FOR AN INDIVIDUAL PATIENT, Computers and biomedical research (Print), 31(4), 1998, pp. 244-256
Authors:
BOISSEL JP
BOUTITIE F
CONNOLLY SJ
CAMM JA
JULIAN D
GENT M
JANSE M
DORIAN P
FRANGIN G
Citation: Jp. Boissel et al., SYNERGY BETWEEN AMIODARONE AND BETA-BLOCKERS AFTER MYOCARDIAL-INFARCTION, Circulation, 98(17), 1998, pp. 470-470
Authors:
IBE W
GROSSER T
LINDEMANN S
BARTLS W
BOISSEL JP
MEYER J
Citation: W. Ibe et al., NITRIC-OXIDE DONORS INDUCE APOPTOSIS IN HUMAN CORONARY AND RABBIT AORTIC SMOOTH-MUSCLE CELLS P53 INDEPENDENTLY, Circulation, 98(17), 1998, pp. 2093-2093
Authors:
DARIUS H
VEIT K
BOISSEL JP
MEYER J
Citation: H. Darius et al., HIGHLY EFFECTIVE LIPOSOME-MEDIATED GENE-TRANSFER OF NO-SYNTHASE-II TOVASCULAR SMOOTH-MUSCLE CELLS, Circulation, 98(17), 1998, pp. 3540-3540
Authors:
LECHAT P
PACKER M
CHALON S
CUCHERAT M
ARAB T
BOISSEL JP
Citation: P. Lechat et al., CLINICAL EFFECTS OF BETA-ADRENERGIC-BLOCKADE IN CHRONIC HEART-FAILURE- A METAANALYSIS OF DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIALS, Circulation, 98(12), 1998, pp. 1184-1191
Authors:
LI W
GUEYFFIER F
BOISSEL JP
GIRARD P
BOUTITIE F
CUCHERAT M
Citation: W. Li et al., IDENTIFICATION AND PREDICTION OF RESPONDERS TO A THERAPY - A MODEL AND ITS PRELIMINARY APPLICATION TO HYPERTENSION, Archives des maladies du coeur et des vaisseaux, 91(8), 1998, pp. 1059-1063
Authors:
NONY P
CUCHERAT M
HAUGH MC
BOISSEL JP
Citation: P. Nony et al., STANDARDIZATION OF TERMINOLOGY IN METAANALYSIS - A PROPOSAL FOR WORKING DEFINITIONS, Fundamental and clinical pharmacology, 11(6), 1997, pp. 481-493
Authors:
BOISSEL JP
HAUGH MC
Citation: Jp. Boissel et Mc. Haugh, CLINICAL-TRIAL REGISTRIES AND ETHICS REVIEW BOARDS - THE RESULTS OF ASURVEY BY THE FICHTRE PROJECT, Fundamental and clinical pharmacology, 11(3), 1997, pp. 281-284